Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Hodgkin Disease × Niacinamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Non-Hodgkin 2 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Lymphoma 1 Hodgkin Disease 1

Interventions

Cyclophosphamide 72 fludarabine phosphate 57 Mycophenolic Acid 46 Whole-Body Irradiation 44 Peripheral Blood Stem Cell Transplantation 43 Tacrolimus 40 Melphalan 39 Etoposide 38 Busulfan 34 fludarabine 33 Rituximab 32 Filgrastim 31 Granulocyte Colony-Stimulating Factor 30 Cyclosporine 26 Brentuximab Vedotin 24 Methotrexate 23 Doxorubicin 23 Antilymphocyte Serum 23 Radiotherapy 22 Cytarabine 18 thymoglobulin 15 Vinblastine 15 Carmustine 15 Dacarbazine 14 Prednisone 13 Nivolumab 13 Stem Cell Transplantation 12 Sirolimus 12 Cyclosporins 12 Vincristine 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00691210 2020-11-20

SAHA

Columbia University

Phase 1 Completed

40 enrolled 13 charts

Hodgkin Disease, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡